Skip to main content

Advertisement

SpringerLink
Log in

Interactions between Δ9-tetrahydrocannabinol and μ opioid receptor agonists in rhesus monkeys: discrimination and antinociception

  • Original Investigation
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

Rationale

Opioid receptor agonists can enhance some effects of cannabinoid receptor agonists, and cannabinoid receptor agonists can enhance some effects of opioid receptor agonists; however, the generality of these interactions is not established.

Objective

This study examined interactions between the discriminative stimulus and antinociceptive effects of μ opioid receptor agonists and Δ9-tetrahydrocannabinol (THC) in rhesus monkeys.

Results

Neither heroin nor morphine (intravenous (i.v.) or subcutaneous (s.c.)) altered the discriminative stimulus effects of THC in monkeys (n = 5) discriminating 0.1 mg/kg THC i.v. In contrast, THC (s.c.) markedly attenuated the discriminative stimulus effect of morphine and heroin in nondependent monkeys (n = 4) discriminating 1.78 mg/kg morphine s.c. Doses of THC that attenuated the discriminative stimulus effects of morphine in nondependent monkeys failed to modify the discriminative stimulus effects of morphine in morphine-dependent (5.6 mg/kg/12 h) monkeys (n = 4) discriminating 0.0178 mg/kg naltrexone s.c. THC also failed to modify the discriminative stimulus effects of naltrexone in morphine-dependent monkeys or the effects of midazolam in monkeys (n = 4) discriminating 0.32 mg/kg midazolam s.c. Doses of THC (s.c.) that attenuated the discriminative stimulus effects of morphine in nondependent monkeys enhanced the antinociceptive effects of morphine (s.c.) in nondependent monkeys. While μ receptor agonists did not alter the discriminative stimulus effects of THC, THC altered the effects of μ receptor agonists in a context-dependent manner.

Conclusion

That the same doses of THC enhance, attenuate, or do not affect morphine, depending on the condition, suggests that attenuation of morphine by THC can result from perceptual masking rather than common pharmacodynamic mechanisms or pharmacokinetic interactions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  • Bowen CA, Fischer BD, Mello NK, Negus SS (2002) Antagonism of the antinociceptive and discriminative stimulus effects of heroin and morphine by 3-methoxynaltrexone and naltrexone in rhesus monkeys. J Pharmacol Exp Ther 302:264–273

    Article  PubMed  CAS  Google Scholar 

  • Braida D, Iosuè S, Pegorini S, Sala M (2004) Δ9-Tetrahydrocannabinol-induced conditioned place preference and intracerebroventricular self-administration in rats. Eur J Pharmacol 506:63–69

    Article  PubMed  CAS  Google Scholar 

  • Breitmeyer BG, Ogmen H (2000) Recent models and findings in visual backward masking: a comparison, review, and update. Percept Psychophys 62:1572–1595

    PubMed  CAS  Google Scholar 

  • Browne RG (1981) Anxiolytics antagonize yohimbine’s discriminative stimulus properties. Psychopharmacology 74:245–249

    Article  PubMed  CAS  Google Scholar 

  • Cichewicz DL (2004) Synergistic interactions between cannabinoid and opioid analgesics. Life Sci 74:1317–1324

    Article  PubMed  CAS  Google Scholar 

  • Colpaert FC (1977) Discriminative stimulus properties of benzodiazepines and barbiturates. In: Lal H (ed) Discriminative stimulus properties of drugs. Plenum, New York, pp 93–106

    Google Scholar 

  • Cook CD, Beardsley PM (2004) Modulation of the discriminative stimulus effects of mu opioid agonists in rats: II. Effects of dopamine D2/3 agonists. Behav Pharmacol 15:75–83

    Article  PubMed  CAS  Google Scholar 

  • Doty P, Dykstra LA, Picker MJ (1994) Discriminative stimulus effects of phencyclidine: pharmacologically specific interactions with delta 9- and delta 8-tetrahydrocannabinol. Drug Alcohol Depend 35:151–158

    Article  PubMed  CAS  Google Scholar 

  • Dykstra LA, Bertalmio AJ, Woods JH (1988) Discriminative and analgesic effects of mu and kappa opioids: in vivo pA2 analysis. Psychopharmacol Ser 4:107–121

    PubMed  CAS  Google Scholar 

  • France CP, de Costa BR, Jacobson AE, Rice KC, Woods JH (1990) Apparent affinity of opioid antagonists in morphine-treated rhesus monkeys discriminating between saline and naltrexone. J Pharmacol Exp Ther 252:600–604

    PubMed  CAS  Google Scholar 

  • Gardner EL, Vorel SR (1998) Cannabinoid transmission and reward-related events. Neurobiol Dis 5:502–533

    Article  PubMed  CAS  Google Scholar 

  • Gauvin DV, Young AM (1989) Evidence for perceptual masking of the discriminative morphine stimulus. Psychopharmacology (Berl) 98:212–221

    Article  CAS  Google Scholar 

  • Gauvin DV, Peirce JM, Holloway FA (1994) Perceptual masking of the chlordiazepoxide discriminative cue by both caffeine and buspirone. Pharmacol Biochem Behav 47:153–159

    Article  PubMed  CAS  Google Scholar 

  • Gerak LR, Gauthier CR, France CP (2003) Discriminative stimulus and antinociceptive effects of dihydroetorphine in rhesus monkeys. Psychopharmacology 166:351–359

    PubMed  CAS  Google Scholar 

  • Grant KA (1999) Strategies for understanding the pharmacological effects of ethanol with drug discrimination procedures. Pharmacol Biochem Behav 64:261–267

    Article  PubMed  CAS  Google Scholar 

  • Greenwald MK, Stitzer ML (2000) Antinociceptive, subjective and behavioral effects of smoked marijuana in humans. Drug Alcohol Depend 59:261–275

    Article  PubMed  CAS  Google Scholar 

  • Haney M (2007) Opioid antagonism of cannabinoid effects: differences between marijuana smokers and nonmarijuana smokers. Neuropsychopharmacology 32:1391–1403

    Article  PubMed  CAS  Google Scholar 

  • Haney M, Bisaga A, Foltin RW (2003) Interaction between naltrexone and oral THC in heavy marijuana smokers. Psychopharmacology (Berl) 166:77–85

    CAS  Google Scholar 

  • Justinova Z, Tanda G, Munzar P, Goldberg SR (2004) The opioid antagonist naltrexone reduces the reinforcing effects of Delta 9 tetrahydrocannabinol (THC) in squirrel monkeys. Psychopharmacology (Berl) 173:186–194

    Article  CAS  Google Scholar 

  • Kline FS, Young AM (1986) Differential modification of pentobarbital stimulus control by d-amphetamine and ethanol. Pharmacol Biochem Behav 24:1305–1313

    Article  PubMed  CAS  Google Scholar 

  • Koek W, Carter LP, Wu H, Coop A, France CP (2006) Discriminative stimulus effects of flumazenil: perceptual masking by baclofen, and lack of substitution with gamma-hydroxybutyrate and its precursors 1,4-butanediol and gamma-butyrolactone. Behav Pharmacol 17:239–247

    Article  PubMed  CAS  Google Scholar 

  • Li JX, Becker GL, Traynor JR, Gong ZH, France CP (2007) Thienorphine: receptor binding and behavioral effects in rhesus monkeys. J Pharmacol Exp Ther 321:227–236

    Article  PubMed  CAS  Google Scholar 

  • Li JX, McMahon LR, France CP (2008) Comparison of naltrexone, 6alpha-naltrexol, and 6beta-naltrexol in morphine-dependent and in nondependent rhesus monkeys. Psychopharmacology 195:479–486

    Article  PubMed  CAS  Google Scholar 

  • Mariathasan EA, White JA, Stolerman IP (1996) Training dose as a decisive factor for discrimination of a drug mixture in rats. Behav Pharmacol 7:364–372

    Article  PubMed  CAS  Google Scholar 

  • Mariathasan EA, Stolerman IP, White JA (1999) AND and AND-OR drug mixture discriminations in rats: generalization to single drugs and drug mixtures. Psychopharmacology (Berl) 143:54–63

    Article  CAS  Google Scholar 

  • McClure RK (2001) The visual backward masking deficit in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 25:301–311

    Article  PubMed  CAS  Google Scholar 

  • McMahon LR (2006) Characterization of cannabinoid agonists and apparent pA2 analysis of cannabinoid antagonists in rhesus monkeys discriminating Delta9-tetrahydrocannabinol. J Pharmacol Exp Ther 319:1211–1218

    Article  PubMed  CAS  Google Scholar 

  • National Research Council (2003) Guidelines for the care and use of mammals in neuroscience and behavioral research. National Academies Press, Washington, DC

  • Navarro M, Carrera MRA, Fratta W, Valverde O, Cossu G, Fattore L, Chowen JA, Gómez R, del Arco I, Villanua Maldonado R, Koob GF, de Fonseca FR (2001) Functional interaction between opioid and cannabinoid receptors in drug self-administration. J Neurosci 21:5344–5350

    PubMed  CAS  Google Scholar 

  • Negus SS, Gatch MB, Mello NK (1998) Effects of mu opioid agonists alone and in combination with cocaine and D-amphetamine in rhesus monkeys trained to discriminate cocaine. Neuropsychopharmacology 18:325–338

    Article  PubMed  CAS  Google Scholar 

  • Nencini P, Woolverton WL (1988) Effects of nimodipine on the discriminative stimulus properties of d-amphetamine in rats. Psychopharmacology 96:40–44

    Article  PubMed  CAS  Google Scholar 

  • Overton DA (1983) Test for a neurochemically specific mechanism mediating drug discriminations and for stimulus masking. Psychopharmacology 81:340–344

    Article  PubMed  CAS  Google Scholar 

  • Platt DM, Grech DM, Rowlett JK, Spealman RD (1999) Discriminative stimulus effects of morphine in squirrel monkeys: stimulants, opioids, and stimulant-opioid combinations. J Pharmacol Exp Ther 290:1092–1100

    PubMed  CAS  Google Scholar 

  • Rios C, Gomes I, Devi LA (2006) Mu opioid and CB1 cannabinoid receptor interactions: reciprocal inhibition of receptor signaling and neuritogenesis. Br J Pharmacol 148:387–395

    Article  PubMed  CAS  Google Scholar 

  • Solinas M, Goldberg SR (2005) Involvement of mu-, delta- and kappa-opioid receptorsubtypes in the discriminative-stimulus effects of delta-9-tetrahydrocannabinol (THC) in rats. Psychopharmacology (Berl) 179:804–812

    Article  CAS  Google Scholar 

  • Solinas M, Panlilio LV, Antoniou K, Pappas LA, Goldberg SR (2003) The cannabinoid CB1 antagonist N-piperidinyl-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl) -4-methylpyrazole-3-carboxamide (SR-141716A) differentially alters the reinforcing effects of heroin under continuous reinforcement, fixed ratio, and progressive ratio schedules of drug self-administration in rats. J Pharmacol Exp Ther 306:93–102

    Article  PubMed  CAS  Google Scholar 

  • Solinas M, Zangen A, Thiriet N, Goldberg SR (2004) Beta-endorphin elevations in the ventral tegmental area regulate the discriminative effects of Delta-9-tetrahydrocannabinol. Eur J Neurosci 19:3183–3192

    Article  PubMed  CAS  Google Scholar 

  • Solinas M, Panlilio LV, Tanda G, Makriyannis A, Matthews SA, Goldberg SR (2005) Cannabinoid agonists but not inhibitors of endogenous cannabinoid transport or metabolism enhance the reinforcing efficacy of heroin in rats. Neuropsychopharmacology 30:2046–2057

    Article  PubMed  CAS  Google Scholar 

  • Stolerman IP, White JA (1996) Impact of training history on discrimination of a drug mixture by rats. Behav Pharmacol 7:483–494

    Article  PubMed  CAS  Google Scholar 

  • Stolerman IP, Mariathasan EA, White JA (1999) Influencing the specificity of drug mixture discriminations by varying the training procedure. Behav Pharmacol 10:657–664

    Article  PubMed  CAS  Google Scholar 

  • Tanda G, Goldberg SR (2003) Cannabinoids: reward, dependence, and underlying neurochemical mechanisms–a review of recent preclinical data. Psychopharmacology (Berl) 169:115–134

    Article  CAS  Google Scholar 

  • Wachtel SR, de Wit H (2000) Naltrexone does not block the subjective effects of oral Delta(9)-tetrahydrocannabinol in humans. Drug Alcohol Depend 59:251–260

    Article  PubMed  CAS  Google Scholar 

  • Wegel RL, Lane CE (1924) The auditory masking of one pure tone by another and its probable relation to the dynamics of the inner ear. Physiol Rev 23:266–285

    Article  Google Scholar 

  • Welch SP, Eads M (1999) Synergistic interactions of endogenous opioids and cannabinoid systems. Brain Res 848:183–190

    Article  PubMed  CAS  Google Scholar 

  • Wiley JL (1999) Cannabis: discrimination of “internal bliss”. Pharmacol Biochem Behav 64:257–260

    Article  PubMed  CAS  Google Scholar 

  • Young AM, Masaki MA, Geula C (1992) Discriminative stimulus effects of morphine: effects of training dose on agonist and antagonist effects of mu opioids. J Pharmacol Exp Ther 261:246–257

    PubMed  CAS  Google Scholar 

Download references

Acknowledgements

The authors thank Christopher Cruz, Blake Harrington, Brandi Taylor, Armando Hernandez, and Ashley Varnon for expert technical assistance.

Author information

Authors and Affiliations

  1. Department of Pharmacology, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive, San Antonio, TX, 78229-3900, USA

    Jun-Xu Li, Lance R. McMahon, Lisa R. Gerak, Ginger L. Becker & Charles P. France

  2. Department of Psychiatry, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA

    Charles P. France

Authors
  1. Jun-Xu Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lance R. McMahon
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Lisa R. Gerak
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ginger L. Becker
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Charles P. France
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Charles P. France.

Additional information

Miscellaneous

This work was supported by USPHS Grants DA05018 (CPF), DA09157 (CPF), DA15468 (LRM), and DA19222 (LRM); CPF is supported by a Senior Scientist Award (DA17918). The authors have no other financial relationships with any organization that is relevant to the results presented in this manuscript.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Li, JX., McMahon, L.R., Gerak, L.R. et al. Interactions between Δ9-tetrahydrocannabinol and μ opioid receptor agonists in rhesus monkeys: discrimination and antinociception. Psychopharmacology 199, 199–208 (2008). https://doi.org/10.1007/s00213-008-1157-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00213-008-1157-0

Keywords

Search

Navigation